featured
Phase I Study of Oral VEGF Inhibitor for Age-Related Macular Degeneration
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation Study
JAMA Ophthalmol 2017 Jun 01;[EPub Ahead of Print], TL Jackson, D Boyer, DM Brown, N Chaudhry, M Elman, C Liang, D O'Shaughnessy, EC Parsons, S Patel, JS Slakter, PJ RosenfeldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.